AMHERST, N.Y., Feb. 28, 2017 -- Allied Motion Technologies Inc. (NASDAQ:AMOT) (“Company”), a global designer and manufacturer of motion control products and solutions, announced that it will release its fourth quarter and full year 2016 results before the opening of financial markets on Tuesday, March 14, 2017. The Company will host a conference call and webcast to review the financial and operating results for the period. A question-and-answer session will follow.
Fourth Quarter and Full Year 2016 Conference Call
| Date: | Tuesday, March 14, 2017 | |
| Time: | 11:00 a.m. Eastern Time | |
| Phone: | (631) 891-4304 or you can pre-register via the link below to receive a return email containing a dial-in number and a unique PIN: http://services.choruscall.ca/DiamondPassRegistration/register?confirmationNumber=10002330&linkSecurityString=19567f110 | |
| Webcast: | http://www.alliedmotion.com/investors | |
A telephonic replay will be available from 2:00 p.m. ET on the day of the call through Tuesday, March 21, 2017. To listen to the archived call, dial (412) 317-6671 and enter replay pin number 10002330 or access the webcast replay via the Company’s website. A transcript will also be posted to the website once available.
About Allied Motion Technologies
Allied Motion (NASDAQ:AMOT), designs, manufactures and sells precision and specialty motion control components and systems used in a broad range of industries within our major served markets, which include Vehicle, Medical, Aerospace & Defense, and Industrial/Electronics. The Company is headquartered in Amherst, NY, has global operations and sells into markets across the United States, Canada, South America, Europe and Asia.
Allied Motion is focused on motion control applications and is known worldwide for its expertise in electro-magnetic, mechanical and electronic motion technology. Its products include brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gear motors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, and other associated motion control-related products. The Company’s growth strategy is focused on becoming the motion solution leader in its selected target markets by leveraging its “technology/know how” to develop integrated precision motion solutions that utilize multiple Allied Motion technologies to “change the game” and create higher value solutions for its customers.
The Company routinely posts news and other important information on its website at http://www.alliedmotion.com/.
For more information, contact: Company Contact: Sue Chiarmonte Allied Motion Technologies Inc. Phone: 716-242-8634 x602 Email: [email protected] Investor Contact: Deborah K. Pawlowski Kei Advisors LLC Phone: 716-843-3908 Email: [email protected]


J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
Want to cut your energy bills? Here’s how five experts are doing it
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 



